TBX21 and lymphoma: In another study [30], no significant difference in OS was observed between positive (≥ 30% of tumor cells) and negative cases for any of the following markers: TBX21, CXCR3, GATA3, or CCR4, among patients with acute‐ and lymphoma‐type ATL.